Evidence map›Paper›PMID 20610625›Full record

ReviewCancer research2010

AACR centennial series: the biology of cancer metastasis: historical perspective.

James E Talmadge, Isaiah J Fidler

Registry-linked trialAbstract readReview
In one paragraph

Review in Cancer research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04529915 (Multicenter Clinical Research for Early Diagnosis of Lung Cancer Using Blood Plasma), which is not on this map. Cited by 571 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
571citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04529915 unknown statusnot on this mapstarted 2020, after this paper: background citation

Multicenter Clinical Research for Early Diagnosis of Lung Cancer Using Blood Plasma

TypeobservationalSponsorKorea University Guro HospitalRan2020 to 2023Enrolled470ConditionsLung CancerArmsExosome sampling
3 · Its place in the literature

Who cites it

571 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The Emerging Role of Circular RNAs in Prostate Cancer: A Systematic Review.Frontiers in cell and developmental biology · 2021
    Pooled it
  2. Trial
  3. Targeting Cancer Hallmarks withInternational journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Cancer Vaccines: Mobilizing Immunity for Targeted Cancer Therapy.Asian Pacific journal of cancer prevention : APJCP · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Tumor Metastasis in the Microcirculation.Advances in experimental medicine and biology · 2026
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

511 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

James E TalmadgeThe University of Nebraska Medical Center, Transplantation Immunology Laboratory, Omaha, Nebraska, USA.
Isaiah J Fidler

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Apar Kishor Ganti · 1985 to 2026
$55.0M
TRANS-NETWORK PROJECTSU54CA143837 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FERRARI, MAURO · 2009 to 2014
$10.8M
NCI NIH HHS 1U54CA143837NCI NIH HHS CA036727NCI NIH HHS CA16672NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA036727NCI NIH HHS U54 CA143837
6 · The paper itself

Abstract

Metastasis resistant to therapy is the major cause of death from cancer. Despite almost 200 years of study, the process of tumor metastasis remains controversial. Stephen Paget initially identified the role of host-tumor interactions on the basis of a review of autopsy records. His "seed and soil" hypothesis was substantiated a century later with experimental studies, and numerous reports have confirmed these seminal observations. An improved understanding of the metastatic process and the attributes of the cells selected by this process is critical for the treatment of patients with systemic disease. In many patients, metastasis has occurred by the time of diagnosis, so metastasis prevention may not be relevant. Treating systemic disease and identifying patients with early disease should be our goal. Revitalized research in the past three decades has focused on new discoveries in the biology of metastasis. Even though our understanding of molecular events that regulate metastasis has improved, the contributions and timing of molecular lesion(s) involved in metastasis pathogenesis remain unclear. Review of the history of pioneering observations and discussion of current controversies should increase understanding of the complex and multifactorial interactions between the host and selected tumor cells that contribute to fatal metastasis and should lead to the design of successful therapy.

Indexed as

Neoplasm MetastasisHumansNeoplasms

Identifiers

PMID20610625
PMCPMC4037932

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.